TORONTO, Sept. 11 /PRNewswire-FirstCall/ - Professor Giovanni Staurenghi, Associate Professor of Ophthalmology, Chairman Eye Clinic, Director II School of Ophthalmology, Department of Clinical Science Luigi Sacco, Sacco Hospital, University of Milan, Italy, today presented at the joint American Society of Retinal Specialists (ASRS), European Vitreo Retinal Society (EVRS) meeting in Cannes, France, the results of a 12 month follow up trial in wet AMD patients treated by either conventional feeder vessel therapy (FVT) or FVT in the presence of indocyanine green (ICG), with both groups being treated with Novadaq’s proprietary OPTTX® System. Professor Staurenghi is the Principal Investigator of this randomized clinical trial.
